Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 177,600 | 137,400 | 112,400 | 340,401 | 191,280 |
| Receivables | 218,100 | 121,500 | 271,100 | 76,955 | 189,489 |
| Inventories | 232,000 | 211,000 | 205,800 | 125,745 | 139,373 |
| TOTAL | $692,700 | $528,500 | $620,800 | $563,148 | $541,308 |
| Non-Current Assets | |||||
| PPE Net | 520,500 | 513,400 | 510,200 | 435,075 | 419,157 |
| Intangibles | 1,010,700 | 1,024,800 | 1,021,300 | 156,991 | 160,903 |
| Other Non-Current Assets | 97,400 | 87,000 | 77,100 | 18,409 | 17,523 |
| TOTAL | $1,628,600 | $1,625,200 | $1,608,600 | $610,475 | $597,583 |
| Total Assets | $2,321,300 | $2,153,700 | $2,229,400 | $1,173,623 | $1,138,891 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 10,100 | 10,100 | N/A | N/A |
| Accounts payable and accrued liabilities | 124,500 | 78,600 | 80,700 | 38,874 | 41,629 |
| Accrued Expenses | 99,500 | 86,500 | 88,900 | 49,232 | 39,811 |
| Other current liabilities | 67,100 | 73,200 | 20,700 | 2,954 | 2,852 |
| TOTAL | $301,200 | $248,400 | $200,400 | $102,014 | $96,813 |
| Non-Current Liabilities | |||||
| Long Term Debt | 830,400 | 732,400 | 784,500 | 13,495 | 13,482 |
| Deferred Revenues | 10,100 | N/A | N/A | 10,790 | 9,750 |
| Other Non-Current Liabilities | 58,200 | 54,300 | 103,600 | 26,122 | 26,995 |
| TOTAL | $1,031,200 | $917,800 | $1,018,100 | $104,960 | $103,732 |
| Total Liabilities | $1,332,400 | $1,166,200 | $1,218,500 | $206,974 | $200,545 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,600 | 51,400 | 51,200 | 50,945 | 50,020 |
| Common Shares | 100 | 100 | 100 | 51 | 51 |
| Retained earnings | 331,700 | 341,300 | 367,300 | 370,728 | 349,783 |
| Other shareholders' equity | -4,700 | -4,100 | -5,100 | -4,308 | -4,057 |
| TOTAL | $988,900 | $987,500 | $1,010,900 | $966,649 | $938,346 |
| Total Liabilities And Equity | $2,321,300 | $2,153,700 | $2,229,400 | $1,173,623 | $1,138,891 |